IRVINE, Calif., Sept. 22, 2017 -- Khang & Khang LLP (the “Firm”) announces the filing of a securities class action lawsuit against Health Insurance Innovations, Inc. (“Health Insurance Innovations” or the “Company”) (Nasdaq:HIIQ). Investors who purchased or otherwise acquired shares between August 2, 2017 and September 11, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the November 10, 2017 lead plaintiff motion deadline.
If you purchased Health Insurance Innovations shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at [email protected].
There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member as well.
According to the Complaint, throughout the Class Period, Health Insurance Innovations made false and/or misleading statements and/or failed to disclose: that the Company’s application for a third-party insurance administrators license with the Florida Office of Insurance Regulation was denied due partly to material errors and omissions; that the Florida Office of Insurance Regulation’s rejection of its application for a third-party insurance administrators license could result in its losing licenses in the other states; and as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. When this news was announced, shares of Health Insurance Innovation dropped in value materially, which caused investors harm according to the Complaint.
If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for almost two decades, by telephone at (949) 419-3834, or by e-mail at [email protected].
This press release may constitute Attorney Advertising in some jurisdictions.
Contact
Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
[email protected]


Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
FDA Approves Mitapivat for Anemia in Thalassemia Patients
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Italy Fines Apple €98.6 Million Over App Store Dominance
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 



